LUNDBECK
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing, and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease, and Alzheimer’s disease. According to the World Health Organization, WHO, more than 700 mil... lion cases of psychiatric and neurological disorders are reported every year. These are serious and life-threatening diseases that affect the quality of life of the patients as well as of their relatives. As these diseases also involve major socio-economic costs, it is imperative for the general society that new and innovative pharmaceuticals are developed. Over the past 50 years, new pharmaceuticals have revolutionized the treatment options, but there remains a large unmet need for new and innovative therapeutics. Focus on R&D is the most important pillar in Lundbeck’s ambition to improve treatment for people living with psychiatric and neurological disorders. We are specialists in our area and have research facilities in Denmark and China, and more than 1,000 employees work in our R&D units. We cooperate closely with strategic partners all over the world, ensuring the best possible foundation for innovation and the development of new treatment solutions. Lundbeck employs approximately 5,300 people worldwide, 1,700 of whom are based in Denmark. We have employees in 55 countries, and our products are registered in more than 100 countries. We have production facilities in China, Denmark, France and Italy and research centers in Denmark and China.
LUNDBECK
Industry:
Health Care Health Diagnostics Medical
Founded:
2000-01-01
Address:
Valby, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.lundbeck.com
Total Employee:
5001+
Status:
Active
Contact:
866-337-6996
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Domain Not Resolving Mobile Non Scaleable Content Nginx Euro IPv6
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Syrona Health
Syrona Health is a digital health solution for personalised gynaecology across life-stages starting from Endometriosis to Menopause.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2019-09-16 | Alder Biopharmaceuticals | Alder Biopharmaceuticals acquired by Lundbeck | 1.95 B USD |
2019-05-06 | Abide Therapeutics | Abide Therapeutics acquired by Lundbeck | 250 M USD |
2018-03-16 | Prexton Therapeutics | Prexton Therapeutics acquired by Lundbeck | 905 M EUR |
2014-05-08 | Chelsea Therapeutics International | Chelsea Therapeutics International acquired by Lundbeck | 658 M USD |
2009-10-07 | Laboratoire Elaiapharm | Laboratoire Elaiapharm acquired by Lundbeck | N/A |
2009-03-19 | Ovation Pharmaceuticals | Ovation Pharmaceuticals acquired by Lundbeck | N/A |
2002-11-21 | Synaptic Pharmaceuticals | Synaptic Pharmaceuticals acquired by Lundbeck | 121 M USD |
Investors List
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - Lundbeck
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2015-08-26 | BenevolentAI | Lundbeck investment in Venture Round - BenevolentAI | 87 M USD |
2014-05-06 | Naurex | Lundbeck investment in Series C - Naurex | 25 M USD |
2011-09-29 | Proximagen | Lundbeck investment in Venture Round - Proximagen | 16 M USD |
Official Site Inspections
http://www.lundbeck.com Semrush global rank: 591.71 K Semrush visits lastest month: 77.42 K
- Host name: server-3-171-100-27.iad12.r.cloudfront.net
- IP address: 3.171.100.27
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109

More informations about "Lundbeck"
Organization and ownership - Lundbeck
In corporate HR, we aim to optimize Lundbeck’s global potential by developing people, the …See details»
Lundbeck - Wikipedia
23 rows H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international …See details»
Org Chart Lundbeck - The Official Board
The organizational chart of Lundbeck displays its 42 main executives including Charl Van Zyl, …See details»
Lundbeck CEO and Key Executive Team | Craft.co
Lundbeck's President & CEO is Charl van Zyl. Other executives include Joerg Hornstein, CFO …See details»
Lundbeck - The Org
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, …See details»
Lundbeck - Crunchbase Company Profile & Funding
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life …See details»
Lundbeck - Research and Development - The Org
The Research and Development team at Lundbeck focuses on pioneering innovative …See details»
Lundbeck - Leadership Team - The Org
The Leadership Team at Lundbeck is responsible for steering the company's strategic direction …See details»
Organization and ownership - Lundbeck
In corporate HR, we aim to optimize Lundbeck’s global potential by developing people, the …See details»
LUNDBECK Mission, Benefits, and Work Culture
At Lundbeck, we take a holistic view of brain health, and believe it needs to be promoted and prioritized. Within brain disorders, we focus our efforts on neurology and psychiatry. Neurological disorders alone are a leading cause of …See details»
This is Lundbeck
The Lundbeck Foundation is the majority owner of Lundbeck. Foundation ownership allows us to stay focused on our areas of specialization. It also means that we are in a position to give back. With donations of approximately DKK …See details»
Lundbeck - Overview, News & Similar companies | ZoomInfo.com
Lundbeck raises financial guidance for 2024 Valby, Denmark, August 20, 2024 - H. Lundbeck …See details»
Dianne Hol appointed new Executive Vice President People
Feb 5, 2024 H. Lundbeck A/S (Lundbeck) today announced the appointment of Dianne Hol to …See details»
Org Chart Lundbeck North America - The Official Board
The organizational chart of Lundbeck North America displays its 7 main executives including …See details»
Lundbeck - Global Health Progress
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life …See details»
No health without mental health - Lundbeck
Dec 2, 2024 With more than 70 years of neuroscience expertise, Lundbeck has developed …See details»
Lundbeck - Sales and Marketing - The Org
The Sales and Marketing team at Lundbeck is responsible for driving the company's …See details»
Organization and ownership - Lundbeck
In corporate HR, we aim to optimize Lundbeck’s global potential by developing people, the …See details»
Working at Lundbeck LLC - Top Workplaces
Lundbeck is a global biopharmaceutical company focusing exclusively on brain health. With …See details»
H. Lundbeck (LON: 0ABR) Market Cap & Net Worth - Stock Analysis
2 days ago H. Lundbeck has a market cap or net worth of 4.38 billion as of December 31, …See details»